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Hkx2 (hexokinase 2) from Saccharomyces cerevisiae was one
of the ﬁrst metabolic enzymes described as a multifunctional
protein. Hxk2 has a double subcellular localization: it functions
as a glycolytic enzyme in the cytoplasm and as a regulator of
genetranscriptionofseveralMig1-regulatedgenesinthenucleus.
To get more insights into the structure–function relationships of
the Hxk2 protein, we followed two different approaches. In the
ﬁrst, we deleted the last eight amino acids of Hxk2 and replaced
Ser
304 with phenylalanine to generate Hxk2wca. Analysis of this
mutant demonstrated that these domains play an essential role
in the catalytic activity of yeast Hxk2, but has no effect on the
regulatory function of this protein. In the second, we analysed
whether amino acids from Lys
6 to Met
15 of Hxk2 (Hxk2wrf)a r e
essential for the regulatory role of Hxk2 and whether there is
an effect on the hexose kinase activity of this protein. In the
present paper, we report that the Hxk2wca mutant protein interacts
with the Mig1 transcriptional repressor and the Snf1 protein
kinase in the nucleus at the level of the SUC2–Mig1 repressor
complex. We have demonstrated that Hxk2wca maintained full
regulatory function because the glucose-repression signalling of
the wild-type machinery is maintained. We also report that the
Hxk2wrf mutantalleleisincapableofglucoserepressionsignalling
because it does not interact with Mig1 at the level of the SUC2–
Mig1 repressor complex. The two mutants, Hxk2wca and Hxk2wrf
retain single functions, as a transcriptional factor or as an enzyme
with hexose-phosphorylating activity, but have lost the original
bifunctionality of Hxk2.
Key words: catalytic domain, glucose repression, glucose
signalling, hexokinase 2, regulatory domain, yeast.
INTRODUCTION
There are three glucose-kinase isoenzymes in Saccharomyces
cerevisiae [1]: isoenzymes 1 and 2 phosphorylate both aldo- and
keto-sugars, whereas glucokinase is speciﬁc for aldo-hexoses.
Isoenzyme 2 of hexokinase (Hxk2) is the predominant glucose-
kinase in S. cerevisiae grown on glucose media [2] and carries
out at least two cellular functions. Classical structural studies
of yeast Hxk2 reveal a well-deﬁned catalytic domain that binds
ATP and hexose (e.g. glucose), allowing transfer of a phosphoryl
group from ATP to the C-6 of the sugar [3–5]. In addition to
the well-known catalytic role of Hxk2, in the last few years, a
new non-canonical function for this protein has been described.
It has been suggested that the Hxk2 protein has special functions
in transcriptional regulation [6]. Functional studies suggest that
the main regulatory role of Hxk2 is produced by interaction
with the transcriptional repressor Mig1 and the Snf1 protein
kinasetogeneratearepressorcomplexinthenucleus[7,8].Under
high-glucose conditions, Hxk2 stabilizes the repressor complex,
blocking Mig1 phosphorylation by Snf1 kinase [9]. Thus the
complex is involved in the glucose-repression signalling of
several Mig1-regulated genes. A determinant for the Hxk2–Mig1
interactionhasbeencharacterizedasaninternalsequencebetween
Lys
6 and Met
15 of the Hxk2 protein [10]. Moreover, it has been
suggested that a fraction of the Hxk2 protein is sequestered to the
nucleus by interacting with Mig1 through this amino acid region.
Despite the large number of studies carried out to identify a
correlation between catalytic activity and regulatory function in
the Hxk2 protein, little is known about the existence of different
domains in the protein that may control each activity. Both
point [11] and null [12] mutations in the HXK2 gene have been
found that blocked glucose repression of certain genes. Since the
glucose-phosphorylating activity in the corresponding extracts
was reduced, the idea that there was a correlation between the
glucose-phosphorylating activity of Hxk2 and glucose repression
appeared a very attractive one [1,13]. However, this idea can
be challenged if we take into account the following results:
(i) when the GLK1 (glucokinase 1) gene is overexpressed in a
 hxk1 hxk2 double-null mutant the transformed strains are still
insensitive to glucose repression, even though a 3-fold increase in
phosphorylating activity is achieved [1], (ii) glucose repression is
not linearly reduced with decreasing kinase activity [14], and (iii)
mutant alleles with low catalytic activity are still fully functional
in glucose signalling [15]. These results suggest that sugar kinase
activity and sugar signalling are mediated at least in part through
separate domains of Hxk2 [14–17]. Thus the correlation between
the catalytic activity of Hxk2 and its ability to mediate glucose
repression appears less likely at present.
In the present study, we have exploited the accumulated
knowledgeonthestructureandtranscriptionalglucose-repression
mechanism of Hxk2, to characterize the catalytic and regulatory
domains of Hxk2. For the ﬁrst time, we describe two mutant
Hxk2 alleles, one without sugar kinase activity, but with almost
full glucose-repression signalling capacity and the other without
regulatory function, but with almost full catalytic activity. Our
results offer strong evidence that there is no correlation between
the regulatory functions of Hxk2 in glucose repression signalling
and its catalytic activity.
Abbreviations used: ADH1, alcohol dehydrogenase 1; ChIP, chromatin immunoprecipitation; DTT, dithiothreitol; GAD, Gal4 activation domain; GBD,
Gal4 DNA-binding domain Glk1, glucokinase 1; GST, glutathione transferase; HA, haemagglutinin; Hkx2, hexokinase 2; KanR, kanamycin-resistance; SD,
synthetic dextrose; SG, synthetic galactose; wca, without catalytic activity; wrf, without regulatory function; YEPD, yeast extract/peptone/dextrose; YEPG,
yeast extract/peptone/galactose.
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EXPERIMENTAL
Strains
The strains used in the present study were derived from
W303.1A (MATα ade2-1 his3-11,15 leu2-3,112 trp1-1 ura3-1)
[18]. We created two loss-of-function alleles of HXK2 by
mutatingthewild-typegeneinplasmidYEp352-HXK2togenerate
HXK2wca (encodes an Hxk2 protein without catalytic activity) and
HXK2wrf (encodes an Hxk2 protein without regulatory function)
genes using a PCR-based mutagenesis protocol. The Kan
R
(kanamycin-resistance) gene was inserted into the XbaI site,
located in the yeast genome 371 bp from the HXK2 stop codon,
of plasmids YEp352-HXK2wca and YEp352-HXK2wrf. Then, by
using these constructs, recombination cassettes were obtained by
PCR; these cassettes contained the mutated HXK2 locus and
the Kan
R marker together with 515 bp from the 5
  genomic
region downstream of the HXK2 gene. These linear DNAs
were integrated into the HXK2 locus of strains W303.1A and
THG1 (MATα leu2-1 ura3-1 lys1-1 hxk1::LEU2 hxk2::LEU2
glk1::LEU2) [19]. To conﬁrm the correct insertion, we PCR-
ampliﬁed the HXK2 locus from strains W303.1Awca, W303.1Awrf,
THG1wca and THG1wrf to detect the presence of the HXK2wca
and HXK2wrf mutant alleles by sequencing analysis. The strain
FMY20VP is derived from DBY2052 (MATα hxk1::LEU2
hxk2-202 ura3-52 leu2-3,2-112 lys2-801 gal2) and contains
the GLK1 gene promoter replaced by the ADH1 (alcohol
dehydrogenase 1) constitutive promoter. Yeast two-hybrid
experiments employed strain Y187 (MATα ura3-52 his3-200
ade2-101 trp1-901 leu2-3,112 gal4  gal80  URA3::GAL1UAS-
GAL1TATA-lacZ). Immunoprecipitation experiments employed
strain FMY303H2 (MATα ade2-1 his3-11,15 leu2-3,112 trp1-
1 ura3-1 hxk2::kanMX4) [20]. This strain has a modiﬁcation
of the SNF1 gene at the chromosomal level and produces
a triple-HA (haemagglutinin) epitope-tagged Snf1 protein. As a
control, in ChIP (chromatin immunoprecipitation) experiments,
strain DBY2052 was used [12].
Construction of Hxk2 mutants
To identify and understand the roles of the different domains of
Hxk2, we designed various truncation, deletion and amino acid
substitutionmutantsandtestedtheirabilitytoconferfunction.The
mutant design was based on hexokinase sequence alignments and
structural data together with the published data on Hxk2 mutants
[3,13,15,21].
To determine the functional role of several amino acids
identiﬁed previously as involved in glucose and ATP binding
to the catalytic site of the enzyme, single amino acid substitution
mutants were constructed to yield the following: in Hxk2S157A,
Ser
157,whichisinvolvedinglucosebindingandisphosphorylated
during γ-phosphate transfer from ATP to glucose [22–24], was
replaced with alanine. In Hxk2T233A, Thr
233, which may interact
with the β-phosphate of ATP [3], was replaced with alanine. In
Hxk2S304F, Ser
304, which is localized in the active centre of the
enzyme [13], was replaced with phenylalanine.
To assess the functional role of the C-terminal region of
Hxk2, both a deletion mutant and a substitution mutant were
constructed. The deletion mutant was constructed by insertion of
a stop codon into a speciﬁc site within the coding region
of the HXK2 gene to yield HXK2 K
478A
485, which encodes an
Hxk2 protein without the last eight amino acids of the C-terminal
end (Hxk2 K
478A
485). The substitution mutant (Hxk2S479A)
was constructed by changing Ser
479 to alanine. Finally, from the
HXK2 K
478A
485 and HXK2S304F genes we obtained the double
mutant HXK2 K
478A
485-S304F (HXK2wca).
To analyse the functional role of the N-terminal region of
the Hxk2, a truncation mutant and a substitution mutant were
constructed.ThetruncationmutantwasobtainedbyPCR-deletion
of 30 bp, between nucleotides +19 and +48, the resulting gene
HXK2 K
6M
15, expressed a truncated Hxk2 protein without the
aminoacidsfromLys
6 toMet
15 (Hxk2wrf).Thesubstitutionmutant
(Hxk2S14A) was obtained by changing Ser
14 to alanine.
Theconstructs were clonedinto theyeast YEp352vector under
the control of the native HXK2 gene promoter. The resulting
plasmids were transformed in DBY2052 ( hxk1 hxk2 GLK1),
a double-mutant strain in which the two hexokinase genes have
been deleted.
Preparation of crude protein extracts
Yeast protein extracts were prepared as follows: yeasts were
grown in 10–20 ml of synthetic or complex galactose medium
[SG−ura (synthetic galactose lacking uracil); YEPG (yeast
extract/peptone/galactose)] containing 2% galactose at 28◦C
to a D600 of 1.0. Then, half of the culture was shifted to
synthetic or complex high-glucose medium [SD−ura (synthetic
dextrose lacking uracil); YEPD (yeast extract/peptone/dextrose)]
containing 2% glucose for 1 h and the other half of the
culture was shifted to synthetic or complex low-glucose
medium [SE−ura (synthetic ethanol lacking uracil); YEPE (yeast
extract/peptone/ethanol)] containing 0.05% glucose plus 3%
ethanol for 1 h. Cells were collected, washed twice with 1 ml of
1 Msorbitolandsuspendedin100μlof50 mMTris/HCl(pH 7.5)
buffer containing 0.2 mM EDTA, 0.5 mM DTT (dithiothreitol),
0.5 mM PMSF, 0.42 M NaCl and 1.5 mM MgCl2. The cells were
broken in the presence of glass beads by one 20 s pulse using a
FastPrep (Thermo Electron) and 400 μl of the same buffer were
added to the suspension. After centrifugation at 14000 rev./min
for 15 min at 4◦C using a Beckman F2402H rotor and Allegra
21R centrifuge (Beckman), the supernatant was used as crude
protein extract.
Enzyme assays
For β-galactosidase activity determinations, crude extracts were
prepared with glass beads as described above and 2 mg/ml ONPG
(o-nitrophenyl β-D-galactopyranoside) was used as a substrate
[25]. Speciﬁc activity was calculated in relation to total protein in
thecrudeextract,usingBSAasthestandard.Invertaseactivitywas
assayed in whole cells as described previously [26] and expressed
as μmol of glucose released per min per 100 mg of cells (dry
weight). Activities are the average of at least ten assays of at least
ﬁve independent colonies.
Immunoblot analysis
Mutant or wild-type yeast cells were grown to a D600 of 1.0
in selective medium containing galactose (2%) and shifted to
high- and low-glucose conditions for 1 h. Cells were collected
by centrifugation at 3000 g for 1 min at 4◦C, and crude extracts
werepreparedasdescribedabove.ForWesternblotting,20–40 μg
of protein was separated by SDS/12% PAGE and transferred by
electroblottingontoenhancedchemiluminescencePVDFtransfer
membrane (Amersham Biosciences), which was then incubated
with an anti-Hxk2 or anti-HA antibody. Horseradish-peroxidase-
conjugated Protein A was used as the secondary reactant. The
complex was detected using the West Pico Chemiluminescent
system (Pierce).
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Yeast two-hybrid analysis
The yeast two-hybrid analysis [27] employed yeast vectors
pGADT7 and pGBDKT7 and host strains Y187 (described
above), in accordance with the Matchmaker two-hybrid system
3 from Clontech. The transformed yeasts were grown in high-
glucose [SD−Leu−Trp (synthetic dextrose lacking leucine and
tryptophan)] medium until reaching a D600 of 0.8. Assays for
β-galactosidase activity followed protocols described previously
[25]. Activities are the average of at least ten assays of at least
ﬁve independently isolated clones. Expression levels of the GAD
(Gal4 activation domain) and GBD (Gal4 DNA-binding domain)
fusion proteins were controlled by Western blot analysis. Strains
lacking the reporter construct did not exhibit any signiﬁcant
activity.
Co-immunoprecipitation assays
Immunoprecipitation experiments were performed by using
whole-cell extracts, from two wild-type yeast strains with
modiﬁed MIG1 and SNF1 genes which code for C-terminal
Mig1 and Snf1 proteins tagged with 3HA epitopes respectively.
Extracts were incubated with anti-Hxk2 antibody (Santa Cruz
Biotechnology) or anti-Pho4 antibody for 1 h at 4◦C. Protein
A–Sepharose beads (Amersham Biosciences) were then added
and incubated for 1 h at 4◦C. After extensive washes with
Staph A buffer (150 mM NaCl, 100 mM Na2HPO4,1 8 m M
NaH2PO4,p H7 . 3 ,2 0% Triton X-100, 1% SDS and 5% sodium
deoxycholate), immunoprecipitated samples were boiled in SDS-
loadingbuffer.ThesupernatantwassubjectedtoSDS/12%PAGE
and detected by Western blot using anti-HA monoclonal anti-
body and horseradish-peroxidase-conjugated Protein A by the
West Pico Chemiluminescent system.
GST (glutathione transferase) pull-down experiments
GST-fusion protein expression vector pGEX-MIG1 was
transformed into Escherichia coli strain BL21(DE3) pLysS.
Cells were grown to a D600 of 0.5–0.8, induced with
0.5 mM IPTG (isopropyl β-D-thiogalactopyranoside) at 37◦C
for 3 h, and collected by centrifugation at 12000 g for
5 min. Cell pellets were resuspended in PBS (150 mM
NaCl, 100 mM Na2HPO4 and 18 mM NaH2PO4,p H 7 . 3 )a n d
sonicated. Insoluble material was removed by centrifugation at
17000 rev./min for 20 min at 4◦C using a Beckman F2402H
rotor and Allegra 21R centrifuge (Beckman). Soluble extracts
were incubated with glutathione–Sepharose 4B (Amersham
Biosciences) for 1 h at 4◦C, washed extensively with
PBS and resuspended in the same buffer. The GST–Mig1
fusion protein coupled to glutathione–Sepharose was incubated
with yeast whole-cell extracts from W303.1A (wild-type) and
the W303.1Awca and W303.1Awrf mutant strains. The cell extracts
were obtained from yeast cells grown in YEPG and shifted to
high- and low-glucose media for 1 h. Beads were gently washed
ﬁve times with 2.5 ml of PBS, boiled in 25 μl of sample-
loading buffer (50 mM Tris/HCl, pH 6.8, 100 mM DTT, 2%
SDS, 0.1% Bromophenol Blue and 10% glycerol), and analysed
by SDS/12% PAGE followed by Western blotting using anti-
Hxk2 antibodies and horseradish-peroxidase-conjugated Protein
A. Bound antibodies were detected using the West Pico
Chemiluminescent system.
ChIP assay
ChIP assays were performed essentially as described previously
[28]. Cells were harvested and disrupted by vortex-mixing in
the presence of glass beads, and the lysate was sonicated
to generate DNA fragments that ranged in size from 200 to
400 bp. To immunoprecipitate HA-tagged proteins, we incuba-
ted the extract overnight at 4◦C with anti-Hxk2 antibodies
[29]. The sequence of primers used for the PCR ampliﬁcation
of the SUC2 promoter region containing the MIG1
element were 5
 -TTATTACTCTGAACAGGA-3
  (sense) and
5
 -AAGTCGTCAAATCTTTCT-3
  (antisense). The sequence
of primers used for the PCR ampliﬁcation of the ACT1
gene were 5
 -GCCTTCTACGTTTCCATCCA-3
  (sense) and 5
 -
GGCCAAATCGATTCTCAAAA-3
  (antisense).
RESULTS
Identiﬁcation of new loss-of-function Hxk2 mutants
To identify the domains of the Hxk2 protein involved in catalytic
activity and glucose-signalling regulation, we generated several
Hxk2 mutants containing one or more substitutions, truncations
or deletions in the amino acid chain (Figure 1A). The different
mutations were used to test their effect on fructose and glucose
growth. The growth properties of each mutant were tested
by spotting serial dilutions of galactose-grown cells on media
containing fructose or glucose as the carbon source. As can be
seen in Figure 1(A), all of the strains grew normally on both
media except the double-mutant  hxk1 hxk2 strain which had
growthdifﬁcultiesinfructosemediumandthe hxk1 hxk2strain
transformed with the YEp352-Hxk2wca plasmid, which had clear
growth problems in both fructose and glucose media.
The Hxk2wca protein content of the  hxk1 hxk2 strain
transformed with the YEp352-Hxk2wca plasmid was evaluated
by Western blot analysis after SDS/PAGE, to determine whether
impairment of growth in fructose medium could be related
to a lower quantity of the Hxk2wca protein. As can be seen
in Figure 1(B), the Hxk2wca mutant protein was expressed in
this strain and migrated at its predicted molecular mass. Since
impairment of Hxk2 function was not due to decreased protein
expression, the growth defect in fructose medium suggests a lack
of hexokinase activity. Moreover, since this strain has a native
GLK1 gene, which is not expressed in cells grown in glucose me-
dium [2], but is fully expressed in cells grown in glucose medium
in the absence of the Hxk2 protein [30], the absence of growth
in glucose medium (Figure 1A) suggests that the Hxk2wca protein
maintains normal glucose-repression signalling.
In order to analyse the regulatory activity of the different
mutants, we have replaced the GLK1 promoter with the
constitutive ADH1 promoter in the  hxk1 hxk2 strain, thus
allowing the expression of Glk1 under high-glucose conditions
in the presence of Hxk2. The strain obtained ( hxk1 hxk2
ADH1p::GLK1) grew in glucose medium at the same rate as
the corresponding wild-type yeast. This strain was transformed
withmulticopyplasmidscontainingdifferentHXK2mutantgenes
under the control of the HXK2 promoter and we measured
the exocellular invertase activity under high- and low-glucose
conditions. The expression of the SUC2 gene for invertase is
repressed in the presence of glucose in the growth medium,
therefore we used the invertase level as a marker for glucose
repression.
Figure 2 clearly shows that the wild-type pheno-
type (low invertase activity under high-glucose conditions)
was restored after transformation of the double-mutant
 hxk1 hxk2ADH1p::GLK1 strain with the wild-type (HXK2)
or the mutant (HXK2wca) genes. When the double-mutant
 hxk1 hxk2ADH1p::GLK1 strain was transformed with the
HXK2wrf gene, the wild-type phenotype was not restored.
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Figure 1 Growth assays and expression of Hxk2 mutants
(A) The double-mutant (DM) DBY2052 ( hxk1 hxk2) strain was transformed with plasmids expressing the indicated HXK2 mutant allele. The strain also contained both the empty vector and the
wild-type HXK2 allele as controls. Ten-fold serial dilutions of cultures grown in selective medium with galactose were spotted on to selective media containing fructose or glucose and incubated at
28◦Cfor48h.Themutants,listedontheleft,arearrangedintheorderinwhichtheyoccurintheprimarysequenceofHxk2.Theﬁrsttworowsshowwild-type(WT,W303.1A)andthedouble-mutant
 hxk1 hxk2 strain transformed with the empty vector (YEp352) as controls. The last two rows show the catalytic mutant allele HXK2wca and the regulatory mutant allele HXK2wrf.( B) Veriﬁcation
of expression of the wild-type and Hxk2 mutant proteins. The double-mutant strain DBY2052 ( hxk1 hxk2GLK1) lacking the two fructose-phosphorylating enzymes was transformed with the
multicopy plasmids indicated. Yeasts were grown to the mid-exponential phase in selective medium with galactose and then shifted to high-glucose medium for 1 h, harvested and lysed in 1%
SDS/PBS containing protease inhibitors. Aliquots of 20 μg of protein/lane were resolved by SDS/12% PAGE. Hxk2 detection was performed using an anti-Hxk2 antibody.
However, this mutant that harbours a truncation between Lys
6
andMet
15 (Hxk2wrf)[10]exhibitednormalgrowthbothinfructose
andglucosemedia(Figure1A),whichsuggestsanormalcatalytic
activity. These results revealed that the Hxk2wca protein exhibited
a complete loss of catalytic function, but maintained a normal
regulatory activity and the Hxk2wrf protein exhibited complete
loss of regulatory function, while maintaining wild-type catalytic
activity.
These consistent results prompted us to obtain, for the ﬁrst
time, stable strains containing the two HXK2 mutant alleles in the
HXK2 locus.
Replacement of the native HXK2 gene by the loss-of-function
HXK2wca and HXK2wrf mutant genes
To construct the loss-of-catalytic and regulatory function
W303.1Awca andW303.1Awrf strains,wereplacedthenativeHXK2
gene with exogenous HXK2wca and HXK2wrf mutant sequences in
the wild-type W303.1A strain.
The glucose-phosphorylating activity of the Hxk2wca and
Hxk2wrf mutant proteins was ﬁrst assessed by measuring the
abilityofstrainscontainingtheseproteinstogrowonmediumwith
glucose as a carbon source (Figure 3A). All of the strains grew
normally on galactose and glucose media, except the W303.1Awca
strain which had a clear growth problem in glucose medium. This
growth problem in may occur because the Hxk2wca protein lacks
catalyticactivityandtheHXK1andGLK1genesarenotexpressed
under high-glucose conditions in the presence of a Hxk2 protein
with normal regulatory function [2,30]. All of the strains grew
well in galactose medium because, in the presence of galactose,
the HXK2 gene has a basal expression similar to that observed for
non-fermentable carbon sources such as ethanol or glycerol [2].
Thus, under these conditions, the GAL genes are expressed and
galactose is used for normal growth.
Although the studies described above measure the growth
capacity on glucose medium of W303.1Awca and W303.1Awrf
strains, they do not establish the Hkx2 catalytic activity of
these strains. To address this issue, we constructed two
new strains by integrating the HXK2wca and HXK2wrf genes
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Figure 2 Effect of Hxk2wca and Hxk2wrf mutations on glucose repression
signalling
The strain FMY20VP with the GLK1 gene under the control of the ADH1 constitutive promoter
was transformed with plasmids containing HXK2wca and HXK2wrf mutant alleles. As controls,
we used the FMY20VP strain transformed both with a plasmid containing the wild-type (WT)
HXK2 gene and the empty plasmid. We have also included invertase activity of wild-type strain
W303.1A. The cells were grown on high-glucose medium (H-Glc, black bars) until a D600 of
1.0 was reached and then transferred to synthetic medium with low glucose for 60min (L-Glc,
white bars). Invertase activity was assayed in whole cells. Results are means+S.D. of ten
measurements obtained with ﬁve independent isolated colonies.
into the HXK2 locus of a triple mutant strain (THG1;
 hxk1 hxk2 glk1). The glucose-phosphorylating activity was
determinedincrudeextractsfromstrainsTHG1wca andTHG1wrf in
a  hxk1 hxk2 glk1 background. As can be seen in Figure 3(B),
the glucose-phosphorylating activity of the THG1wca strain was
identical with that of the THG1 strain. Interestingly, the pattern
of activity for the THG1wrf strain was similar to that of the
W303.1A strain. Thus our results indicate that the W303.1Awrf
strain maintained a normal (wild-type) Hxk2 catalytic activity,
but the W303.1Awca strain had lost its catalytic function.
To investigate the Hxk2-dependent glucose signalling function
of the W303.1Awca and W303.1Awrf strains (Figure 3C), the cells
were grown in galactose medium to a D600 of 1.0 and then shifted
to high- and low-glucose media for 1 h. Finally the exocellular
invertase activity was determined in the whole cells. The speciﬁc
activity of invertase shows strong derepression on both high- and
low-glucose media in the presence of the Hxk2wrf mutant protein
(W303.1Awrf strain). On high- and low-glucose media, in the
presence of the Hxk2wca protein (W303.1Awca strain), wild-type
repression and derepression signalling was observed.
These results indicate that we had constructed two new
strains of S. cerevisiae with loss-of-catalytic (W303.1Awca)a n d
regulatory (W303.1Awrf) functions.
The Hxk2wca mutant protein interacts with the Mig1 transcriptional
repressor and the Snf1 protein kinase
Current evidence suggests that the main role of S. cerevisiae
Hxk2 in the glucose signalling pathway is achieved through its
interactionwithbothMig1andSnf1proteins.Ithasbeenproposed
thatHxk2inhibitsthephosphorylationoftheMig1repressorwhen
the cells are growing under high-glucose conditions, maintai-
ning the transcriptional repression of target genes. To investigate
the mechanism by which the Hxk2wca mutant protein signals
Figure 3 Growth assays, catalytic activity and regulatory function of
W303.1Awca and W303.1Awrf strains
(A) The strains W303.1Awca and W303.1Awrf have the HXK2wca and HXK2wrf alleles integrated
intotheHXK2 locusofstrainW303.1Arespectively.Ten-foldserialdilutionsofculturesgrownin
YEPGwerespottedontocomplexmediacontainingglucoseorgalactoseandincubatedat28◦C
for48 h.Thewild-type(WT)W303.1Astrainwasusedascontrol.(B)TheTHG1wca andTHG1wrf
strains have the HXK2wca and HXK2wrf alleles integrated into the HXK2 locus of strain THG1
respectively. The wild-type W303.1A and the triple mutant strain THG1 ( hxk1 hxk2 glk1)
were used as controls. The cells were grown on YEPG medium until a D600 of 1.0 was reached
andthentransferredtoYEPDmediumfor60min.Glucose-phosphorylatingactivitywasassayed
incrudeextracts.Resultsaremeans+S.D.oftenmeasurementsobtainedwithﬁveindependent
isolated colonies. (C) The strains W303.1Awca and W303.1Awrf were grown on YEPG medium
until a D600 of 1.0 was reached and then transferred to high-glucose (H-Glc, black bars) and
low-glucose (L-Glc, white bars) complex media for 60min. Invertase activity was assayed in
whole cells. Results are means+S.D. of ten measurements obtained with ﬁve independent
isolated colonies.
glucose repression in the W303.1Awca strain and the loss-of-
repressing function in the W303.1Awrf strain, we performed two-
hybrid,co-immunoprecipitationandGSTpull-downexperiments.
First, we monitored the possible physical interaction between
Mig1 and the Hxk2 mutant proteins Hxk2wca and Hxk2wrf using
a yeast two-hybrid assay. Plasmid pGBKT7-Mig1 (expressing
a GBD fusion to Mig1) was co-transformed with a plasmid
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Figure 4 Yeast two-hybrid interaction of Mig1 with Hxk2wca and Hxk2wrf
during high-glucose-grown conditions
(A) Mig1 fused to the GBD were individually co-transformed into yeast strain Y187 with
constructs encoding GAD or GAD fused to wild-type Hxk2 and the mutant alleles Hxk2wca
and Hxk2wrf. The wild-type Hxk2 fused to the GAD was also co-transformed into yeast
strain Y187 with the construct encoding the GBD. The transformed yeast cells were grown
in SD medium lacking appropriate supplements to maintain selection for plasmids and were
harvested at early-exponential phase (D600 of 0.6) from high-glucose conditions (H-Glc).
Protein–protein interactions were examined in each transformant by the quantitative assay
method for β-galactosidase activity. Results are means+S.D. of ten measurements obtained
withﬁveindependentisolatedclones.Strainslackingthereporterconstructsdidnotexhibitany
signiﬁcant activity. (B) Western blot analysis of the expression of different HXK2 alleles under
high-glucose conditions.
expressing a fusion of the GAD with Hxk2, Hxk2wca or Hxk2wrf
into an appropriate reporter strain. The interaction between the
selected proteins was monitored by measurement of the β-
galactosidaseactivityunderhigh-glucoseconditions.Asshownin
Figure 4(A), the GAD–Hxk2 and GAD–Hxk2wca fusion proteins
produced a strong interaction with GBD–Mig1. However, this
interaction was absent from a GAD–Hxk2wrf mutant, indicating
that the decapeptide between Lys
6 and Met
15 of Hxk2 is
essential for Hxk2 interaction with Mig1, as observed previously
[9]. Similar levels of all protein fusions were detected in all
cases (Figure 4B). To conﬁrm the interaction, we performed
co-immunoprecipitation and GST pull-down assays. First, we
examinedtheabilityofHxk2wca andHxk2wrf tointeractwithMig1
byusinganimmunoprecipitationassay.Cellextractsfromastrain
with a modiﬁed MIG1 gene which codes for a C-terminal Mig1
protein tagged with 3HA epitopes, were immunoprecipitated
with the antibodies indicated in Figure 5(A). The resulting
immunoprecipitates were assayed for the presence of Mig1–
HA by immunoblot analysis with anti-HA antibodies. As shown
in Figure 5(A) (lanes 1 and 3), a strong and speciﬁc signal
of Mig1 was observed both with samples immunoprecipitated
from extracts of wild-type or Hxk2wca strains grown under high-
glucose conditions. However, signals were not observed when
the experiment was performed using extracts of wild-type or
Hxk2wca strains grown under low-glucose conditions, or when
the experiment was performed using the strain expressing the
Hxk2wrf protein. The lack of interaction cannot be attributed
to lack of expression, as the Hxk2wrf protein was detected by
Western blotting using an anti-Hxk2 antibody. When an anti-
Pho4 antibody or no antibody was used to detect non-speciﬁc
immunoprecipitation and non-speciﬁc protein binding to the anti-
HA antibody respectively, no signals were observed. Thus this
interaction is dependent on the production of HA-tagged Mig1 as
well as an anti-Hxk2 antibody.
In order to determine the phosphorylation status of Mig1 in
the Hxk2wca and Hxk2wrf mutant cells, we examined Mig1 phos-
phorylation in vivo in response to high and low levels of glucose
(Figure 5B). For this purpose, we prepared extracts from wild-
type, Hxk2wca and Hxk2wrf mutant strains transformed with the
Mig1–HA construct. The transformed yeast cells were grown in
the presence of high or low glucose. The mobility of Mig1 on
SDS/PAGE was examined by Western blotting using an anti-
HA antibody. The mobility of Mig1 varies depending on its
phosphorylation state [31]. As shown in Figure 5(B), in the
presence of either Hxk2 or Hxk2wca proteins, Mig1 from low-
glucose grown cells displays a slight shift in molecular mass,
resulting in decreased mobility, in comparison with Mig1 from
high-glucose-grown cells. However, in the presence of Hxk2wrf,
Mig1frombothhigh-andlow-glucose-growncellshaddecreased
mobility (Figure 5B, lanes 5 and 6) indicating that the protein is
phosphorylated. This result suggests that the Snf1 protein kinase
complex assumes an active conformation even in the presence of
glucose, a similar result to that obtained in the absence of Hxk2
[27,32].
To conﬁrm the interaction of Mig1 with Hxk2wca,w ea l s o
employed the GST pull-down technique. We used extracts from
the Hxk2wca- and Hxk2wrf-producing strains and a bacterially
produced GST–Mig1 fusion protein. As shown in Figure 5(C)
(lanes1and2),astrongandspeciﬁcbandwasobservedinextracts
from wild-type and Hxk2wca strains grown under high-glucose
conditions. No retention was detected with the extracts obtained
from low-glucose-grown cells or with extracts from the Hxk2wrf
straingrownunderbothhigh-andlow-glucoseconditions.Similar
amounts of Hxk2, Hxk2wca and Hxk2wrf proteins were detected in
theseimmunoprecipitatesbyimmunoblotanalysiswithanti-Hxk2
antibody (Figure 5D).
Previous data indicate that Hxk2, Mig1 and Snf1 form a
complex at the nuclear level and that Hxk2 functions as a bridge
between Snf1 and Mig1, interacting with Snf1 to inhibit Mig1
phosphorylationatSer
311 underhigh-glucoseconditions[9].Thus
it is tempting to speculate that the loss-of-function mutants of
Hxk2 could have differences in their capacity to interact with the
Snf1 protein. To address these possibilities, we examined the
ability of Hxk2wca and Hxk2wrf proteins to interact with Snf1
by using an immunoprecipitation assay. Cell extracts from a
strain with a modiﬁed SNF1 gene which codes for a C-terminal
Snf1 protein tagged with 3HA epitopes were immunoprecipitated
with the antibodies indicated in Figure 6. The resulting
immunoprecipitates were assayed for the presence of Snf1–HA
by immunoblot analysis with anti-HA antibodies. As shown in
Figure 6 (lanes 3 and 4, and 5 and 6), a strong signal of Snf1–
HA protein was observed both with samples immunoprecipitated
from high- and low-glucose-grown cultures. When an anti-
Pho4 antibody or no antibody was used to detect non-speciﬁc
immunoprecipitation and non-speciﬁc protein binding to anti-
HA antibody respectively, no signals were observed. Similar
amounts of Hxk2, Hxk2wca and Hxk2wrf proteins were detected in
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Figure 5 Interaction of Hxk2wca and Hxk2wrf with Mig1
(A) In vivo co-immunoprecipitation of HA–Mig1 with Hxk2wca and Hxk2wrf. The W303.1A, W303.1Awca and W303.1Awrf strains, transformed with plasmid pWS93/Mig1 which encoded an HA-tagged
Mig1 protein, were grown in SG medium lacking appropriate supplements to maintain selection for plasmid, until a D600 of 1.0 was reached and then shifted to high- (H-Glc) and low- (L-Glc)
glucose conditions for 1h. The cell extracts were immunoprecipitated with a polyclonal anti-Hxk2 antibody (lanes 1–6) or a polyclonal antibody against Pho4 (lanes 7 and 8). Immunoprecipitates
were separated by SDS/12% PAGE, and co-immunoprecipitated HA–Mig1 was visualized on a Western blot with a monoclonal anti-HA antibody. The level of immunoprecipitated Hxk2 in the
blotted samples was determined by using an anti-Hxk2 antibody. (B) Mig1 phosphorylation in response to Hxk2wca and Hxk2wrf availability. Cells, from wild-type (WT), Hxk2wca and Hxk2wrf strains
transformed with the HA–Mig1 construct (plasmid pWS93/Mig1), were grown in SG medium lacking appropriate supplements to maintain selection for plasmid, until a D600 of 1.0 was reached and
then shifted to high- (H-Glc) and low- (L-Glc) glucose conditions for 1 h. The Mig1 protein was detected from total cell extracts by SDS/12% PAGE followed by immunoblotting with an anti-HA
antibody. The phosphorylated forms of Mig1 are indicated as HA-Mig1-P (phosphorylated) and HA-Mig1 (dephosphorylated). (C) GST pull-down assays of the interaction of Hxk2wca and Hxk2wrf
proteins with Mig1. A GST–Mig1 fusion protein was puriﬁed on glutathione–Sepharose columns. Equal amounts of GST–Mig1 were incubated with cell extracts from a wild-type strain (W303.1A)
and the mutant strains W303.1Awca and W303.1Awrf. The yeast strains were grown in YEPG medium until a D600 of 0.6 was reached and then shifted to high- (H-Glc) and low- (L-Glc) glucose
conditions for 1 h. For the control samples, GST protein was also incubated with the H-Glc and L-Glc cell extracts, but no signals were detected (lanes 5 and 6). (D) The level of Hxk2 present in the
different extracts used in (C) was determined by Western blotting using an anti-Hxk2 antibody. The Western blots shown are representative of results obtained from four independent experiments.
theseimmunoprecipitatesbyimmunoblotanalysiswithanti-Hxk2
antibody. Thus the interactions between Snf1 and both Hxk2wca
and Hxk2wrf are dependent on the production of HA-tagged Snf1
as well as anti-Hxk2 antibody.
These results provide strong evidence that the Hxk2wca mutant
protein signals glucose repression in yeast by interacting with the
Mig1 repressor. Moreover, the Hxk2wca mutant protein probably
plays aroleidentical with thatof Hxk2actingasabridge between
Snf1 and Mig1, to inhibit Mig1 phosphorylation by Snf1 at Ser
311
under high-glucose conditions.
Furthermore, since the interaction between Mig1 and Hxk2wca
wasdetectedonlyunderhigh-glucoseconditions,ourdatasuggest
that both proteins interact in a glucose-dependent manner. Our
resultsalsosuggestthatHxk2wrf isincapableofglucose-repression
signalling because it does not interact with Mig1 either in vivo
or in vitro. This result conﬁrms that the ten-amino-acid motif
between Lys
6 and Met
15, identiﬁed previously as essential for
Hxk2 translocation to the nucleus [7], is required for the Hxk2–
Mig1 interaction.
The Hxk2wca mutant protein binds in vivo to the SUC2–Mig1
repressor complex
Previous reports have demonstrated that Hxk2 participates in
the SUC2–Mig1 repressor complex through an interaction with
Figure 6 Interaction of Hxk2wca and Hxk2wrf with Snf1
Co-immunoprecipitation of HA–Snf1 with Hxk2wca and Hxk2wrf. The FMY303H2 strain,
which encoded an HA-tagged Snf1 protein, was transformed with plasmids YEp352/Hxk2,
YEp352/Hxk2wca and YEp352/Hxk2wrf. The cells were grown in SG medium lacking appropriate
supplements to maintain selection for plasmid, until a D600 of 1.0 was reached and then
shifted to high- (H-Glc) and low- (L-Glc) glucose conditions for 1h. The cell extracts
were immunoprecipitated with a polyclonal anti-Hxk2 antibody or a polyclonal antibody
against Pho4 (lanes 7 and 8). Immunoprecipitates were separated by SDS/12% PAGE, and
co-immunoprecipitatedHA–Snf1wasvisualizedbyWesternblottingwithamonoclonalanti-HA
antibody.ThelevelofimmunoprecipitatedHxk2intheblottedsampleswasdeterminedbyusing
an anti-Hxk2 antibody.
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Figure 7 In vivo binding of Hxk2wca to the MIG1 element of the SUC2 promoter
(A) Wild-type (WT) W303.1A, the mutant strains W303.1Awca and W303.1Awrf and the double-mutant strain DBY2052 ( hxk1 hxk2) were grown to mid-exponential phase in YEPG medium and
then shifted to high- (H-Glc) and low- (L-Glc) glucose conditions for 1 h. Cell extracts were prepared, immunoprecipitated with anti-Hxk2 antibodies and the DNA fragments were ampliﬁed by PCR
using the combination of oligonucleotides indicated in the Materials and methods section. The ampliﬁed fragments were resolved by agarose gel electrophoresis. Migration of standard markers is
indicated on the right. A ChIP assay representative of three independent experiments is shown. (B) Veriﬁcation of expression of the wild-type and Hxk2 mutant proteins. The double-mutant strain
DBY2052 ( hxk1 hxk2GLK1) lacking the two fructose-phosphorylating enzymes was used as control. Yeasts were grown to mid-exponential phase in complex medium with galactose,a n dt h e n
shifted to high-glucose medium for 1h. The cells were harvested and lysed in 1% SDS/PBS containing protease inhibitors. Aliquots of 20 μg of protein/lane were resolved by SDS/12% PAGE.
Hxk2 detection was performed using an anti-Hxk2 antibody.
the Mig1 protein and not by direct binding to DNA [6–9]. As
Hxk2wca and Mig1 may form an in vivo complex (see above),
we investigated the biological signiﬁcance of this interaction
by determining whether Hxk2wca localized in the SUC2–Mig1
repressor complex in a glucose-dependent manner. To test this
hypothesis, we used ChIP assays. Our results show that, in
cells grown in high-glucose medium, both Hxk2 and Hxk2wca
proteins were recruited to a DNA fragment of the SUC2 promoter
containing the Mig1-binding site (Figure 7A, lanes 1 and 3).
Conversely, in low-glucose medium, Hxk2 and Hxk2wca binding
to the SUC2–Mig1 complex was abolished (Figure 7A, lanes 2
and 4).
Interestingly,bindingoftheHxk2proteintotheMig1siteofthe
SUC2promoterwasdependentonthepresenceofthedecapeptide
between Lys
6 and Met
15, since in W303.1Awrf cells, no binding
of Hxk2wrf (lacks interaction with Mig1) to the SUC2 promoter
was observed under any growth condition (Figure 7A, lanes 5
and 6). The lack of DNA ampliﬁcation cannot be attributed to
lack of expression as the Hxk2wrf protein because it was detected
by Western blotting using an anti-Hxk2 antibody (Figure 7B).
No DNA ampliﬁcation was observed when we used cells without
Hxk2 or oligonucleotides to amplify the ACT1 promoter by PCR.
Taking all of these results together, we suggest that Hxk2wca
forms a complex with Mig1 and Snf1 similar to that of Hxk2, and
that this complex is involved in the glucose-regulated expression
of the SUC2 gene. Thus Hxk2wca maintains its regulatory function
because it maintains the glucose signalling wild-type machinery,
whereas Hxk2wrf mutant protein lacks the regulatory function,
because it is unable to form the repressor complex with Mig1
protein.
DISCUSSION
The role of the Hxk2 protein in glucose repression has been a
matter of controversy for many years. Our data challenge the
view that its role in glucose-repression signalling is directly
related to its catalytic activity. This view was based on the
inverse correlation between Hxk2 and invertase activity in a
collection of random Hxk2 mutants [1,12]. Although previous
results have shown Hxk2 mutants with low catalytic activity
that are still functional in glucose signalling [15], a complete
separation of the two activities never has been achieved. We
have used the accumulated knowledge about the structure of
the catalytic and regulatory domains of the Hxk2 protein to
design a set of new mutations. We probed the role of these Hxk2
mutations in the following Hxk2 functions: catalytic activity,
regulatory activity and interactions with proteins essential for
these functions. By screening for suppression of the catalytic
activitywhilemaintainingtheregulatoryfunctionandsuppression
of the regulatory function and maintaining the catalytic activity
in the Hxk2 protein, we have isolated novel alleles of the HXK2
genethathavebeenlongsoughtafter.Theresultsconﬁrmwhathas
been suspected for some time: that Hxk2 mediates catalytic and
regulatory activities through different domains in the protein. The
twoseparation-of-functionmutantsisolated,Hxk2wca andHxk2wrf,
are remarkable since they convert the Hxk2 from a bifunctional
protein into a single-function protein with activity as a mediating
factor in transcription (Hxk2wca) or as an enzyme with hexose-
phosphorylating activity (Hxk2wrf).
The Hxk2wca mutant protein encodes an Hxk2 protein without
the last eight C-terminal amino acids and a replacement of
Ser
304, which is located in the active centre of the enzyme, with
phenylalanine. The Hxk2wrf mutant is an Hxk2 protein with an
internaldeletionbetweenaminoacidsLys
6 andMet
15.Sincethere
is no overlap between the two domains controlling the Hxk2
catalytic and regulatory functions respectively, in the present
study, we demonstrated that a correlation between catalytic
activity and regulatory function in this protein does not exist.
In the glucose-repression signalling pathway, two major
mediators are the proteins Mig1 and Hxk2. Under high-glucose
conditions, nuclear Hxk2 interacts both with Mig1 and the Snf1
subunit of the Snf1 protein kinase complex to establish the
repression state of several genes. Hxk2 interacts strongly with
Mig1inhigh-glucose-growncellsandpreviousﬁndingsimplicate
Ser
311 of Mig1 as a critical residue for this interaction [9]. The
interactionbetweenSnf1andHxk2wasdetectedbothunderhigh-
andlow-glucoseconditionsandthedatasuggestthatbothproteins
interact constitutively [9].
In low-glucose-grown cells, the Hxk2 interaction with Mig1
is abolished and a transient increase in interaction between
Snf1 and Mig1 was detected [33]. This interaction pattern
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potentially stimulates Mig1 phosphorylation by Snf1 kinase at
Ser
311. Phosphorylation of Ser
311 results in most Mig1 being
exported from the nucleus to the cytoplasm, and, ultimately,
the derepression of genes regulated by the Hxk2–Mig1 glucose-
repression signalling pathway.
To analyse the mechanism by which the loss-of-function
mutants operate through the regulatory machinery, we have
determined protein–protein interactions with Mig1 and Snf1
proteins, and protein–DNA interactions with the Mig1-binding
site of the SUC2 promoter. Since the Hxk2–Mig1 complex plays
an essential role in glucose-repression signalling of several genes
[7,9], detailed knowledge of the interaction between Hxk2wca and
Hxk2wrf mutant proteins with Mig1 is required to understand how
these two mutants operate in the glucose-repression mechanism.
One of the important observations described in the present study
is that two-hybrid assays, co-immunoprecipitation and GST pull-
down experiments with puriﬁed Mig1 protein demonstrated that
Hxk2wrf does not interact with Mig1 under both high- and low-
glucose conditions. The lack of interaction between Hxk2wrf and
Mig1 implies a loss of regulatory function. However, two-hybrid
assays, co-immunoprecipitation and GST pull-down experi-
ments with puriﬁed Mig1 protein demonstrated that Hxk2wca
interacted with Mig1 under high- but not low-glucose conditions,
a similar behaviour to the wild-type Hxk2.
Although the interaction between Snf1 and Hxk2wrf or Hxk2wca
wasdetectedbothunderhigh-andlow-glucoseconditionsandour
data suggest that these proteins interact constitutively with Snf1,
a loss of regulatory function was detected in the Hxk2wrf mu-
tant protein. Lack of the regulatory function of the Hxk2wrf
protein could be explained because the Hxk2 protein operates
as a bridge between Snf1 and Mig1 and is required to inhibit
Mig1phosphorylationatSer
311 bySnf1kinaseunderhigh-glucose
conditions [9]. Since Hxk2wrf has lost its interaction capacity
with Mig1 under high-glucose conditions, the Mig1 protein
could be phosphorylated by Snf1, and both Mig1 and Hxk2 are
exported from the nucleus to the cytoplasm by the Msn5 [34]
and Xpo1 (Crm1) exporters [35] respectively. Thus, under high-
glucoseconditions,severalgenescontrolledbytheMig1repressor
complex are expressed because the Hxk2wrf protein has lost its
regulatory function.
This hypothesis is supported by the following facts: (i)
although it has been reported that Snf1 is inactive under high-
glucose conditions [31], it has also been described that the
non-phosphorylated form of Snf1 may have a direct role in
controlling the expression of the TRK1 and TRK2 genes of
the Trk high-afﬁnity potassium-uptake system [36]; (ii) in the
absence of Hxk2, the Snf1 protein kinase complex assumes
an active conformation even in the presence of glucose [9,33],
because the Mig1 protein from both high- and low-glucose-
grown cells has decreased electrophoretic mobility, indicating
that the protein is phosphorylated [9]; (iii) in the absence of
Snf1 or both Hxk2 and Snf1, Mig1 has an increased mobility
pattern, indicating that the protein is dephosphorylated [9,33,37];
(iv) in Hxk2wrf mutants, lacking a domain required for Mig1–
Hxk2 interaction, Mig1 is phosphorylated under both high- and
low-glucose conditions (Figure 5A). Thus our data strongly
suggest that the Hxk2 interaction with Mig1 under high-glucose
conditions might prevent phosphorylation of Mig1 by Snf1.
In the present study, we have demonstrated that Hxk2wrf is
unable to signal glucose repression in S. cerevisiae because it
was not present in the Mig1 repressor complex of the SUC2
promoter. Furthermore, we have also demonstrated that Hxk2wca
is able to signal glucose repression in S. cerevisiae because it is
physically associated with the Mig1 protein repressor, and ChIP
assays conﬁrmed that both Hxk2 and Hxk2wca interacted with
Mig1 in DNA fragments containing the MIG1 site of the SUC2
promoter. Therefore our results suggest that both Hxk2wca and
Hxk2 use similar mechanisms to regulate glucose signalling in
yeast.
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